European Heart Journal - Cardiovascular Pharmacotherapy
Oxford University Press
United Kingdom
journal
SJR by Edition
Subject Categories
- Cardiology and Cardiovascular MedicineQ1
- Pharmacology (medical)Q1
Areas: Medicine
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
2055-6837, 2055-6845
SJR Best Quartile
Q1
Region
Western Europe
Citations per Document (2 years)
4.32
References per Document
27.46
Coverage
2015-2026
Scope
The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, English language, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology. It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area. While the focus is on clinical topics, basic research articles from fields such as physiology and molecular biology which contribute to an understanding of cardiovascular drug therapy are also considered, such as articles relevant to new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects.
Metrics from SCImago Journal Rank 2025. View on SCImago